- Home
- RXRX vs NZF Comparison
RXRX vs NZF Comparison
Compare RXRX & NZF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- NZF
- Stock Information
- Founded
- RXRX 2013
- NZF 2001
- Country
- RXRX United States
- NZF United States
- Employees
- RXRX N/A
- NZF N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- NZF Finance Companies
- Sector
- RXRX Health Care
- NZF Finance
- Exchange
- RXRX Nasdaq
- NZF Nasdaq
- Market Cap
- RXRX 2.6B
- NZF 2.4B
- IPO Year
- RXRX 2021
- NZF N/A
- Fundamental
- Price
- RXRX $9.28
- NZF $12.62
- Analyst Decision
- RXRX Buy
- NZF
- Analyst Count
- RXRX 4
- NZF 0
- Target Price
- RXRX $8.75
- NZF N/A
- AVG Volume (30 Days)
- RXRX 32.2M
- NZF 496.8K
- Earning Date
- RXRX 02-28-2025
- NZF 01-01-0001
- Dividend Yield
- RXRX N/A
- NZF 4.67%
- EPS Growth
- RXRX N/A
- NZF N/A
- EPS
- RXRX N/A
- NZF N/A
- Revenue
- RXRX $65,184,000.00
- NZF N/A
- Revenue This Year
- RXRX $61.89
- NZF N/A
- Revenue Next Year
- RXRX $30.83
- NZF N/A
- P/E Ratio
- RXRX N/A
- NZF N/A
- Revenue Growth
- RXRX 37.64
- NZF N/A
- 52 Week Low
- RXRX $5.60
- NZF $9.82
- 52 Week High
- RXRX $15.74
- NZF $12.29
- Technical
- Relative Strength Index (RSI)
- RXRX 58.05
- NZF 56.45
- Support Level
- RXRX $7.33
- NZF $12.57
- Resistance Level
- RXRX $12.36
- NZF $12.73
- Average True Range (ATR)
- RXRX 1.01
- NZF 0.09
- MACD
- RXRX 0.24
- NZF 0.01
- Stochastic Oscillator
- RXRX 43.69
- NZF 63.33
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About NZF Nuveen Municipal Credit Income Fund
Nuveen Municipal Credit Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and to enhance portfolio value relative to the municipal bond market by investing in an actively managed portfolio of tax-exempt municipal securities.